Q3 Earnings Alert! Plan early for this week’s stock reports with all key data in 1 placeSee list

Steward Health CEO who refused to testify to US Senate will step down

Published 09/28/2024, 03:50 PM
Updated 09/29/2024, 08:40 AM
© Reuters. St. Elizabeth's Medical Center, Boston, May 6, 2024. REUTERS/Nate Raymond

WASHINGTON (Reuters) - Ralph de la Torre will step down as CEO of troubled Steward Health Care next week, the company said on Saturday, after he was held in criminal contempt by the U.S. Senate for refusing to testify about cost-cutting decisions at the group's 31 hospitals before it filed for bankruptcy.

In a statement, the Dallas-based company said de la Torre would no longer serve as its CEO and chairman as of Oct. 1 as part of an agreement in principle reached earlier this month.

A spokesperson for de la Torre confirmed that the former heart surgeon "has amicably separated from Steward on mutually agreeable terms," and "he will continue to be a tireless advocate for the improvement of reimbursement rates for the underprivileged patient population."

The Senate unanimously voted on Wednesday to hold de la Torre in criminal contempt of Congress after he declined to attend a Sept. 12 hearing before the Senate Committee on Health, Education, Labor and Pensions, which was probing Steward's financial troubles. De la Torre had been subpoenaed to attend the hearing.

Steward, the largest privately owned hospital network in the U.S., filed for bankruptcy in May, seeking to sell all of its hospitals and address $9 billion in debt. The company has sold several hospitals since that filing.

© Reuters. St. Elizabeth's Medical Center, Boston, May 6, 2024. REUTERS/Nate Raymond

"Dr. de la Torre urges continued focus on this mission and believes Steward's financial challenges put a much-needed spotlight on Massachusetts' ongoing failure to fix its healthcare structure and the inequities in its state system," his spokesperson said.

A number of hospitals affected by Steward's financial troubles were based in Massachusetts.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.